Skip to main content
Earnings Labs
Tvardi Therapeutics, Inc. logo

Tvardi Therapeutics, Inc. (TVRD)

NASDAQ·Healthcare·Biotechnology

$2.70

+2.66%

Mkt Cap $37.34M

Analyst Ratings

No recent rating data.

Price Target (5 analysts)

$3.00

Range $3.00$3.00

Implied Upside

+11.1%

Consensus $3.00 vs current $2.70